Replacement therapy in
Primary immunodeficiency syndromes (PID) such as:
- congenital agammaglobulinaemia and hypogammaglobulinaemia

-common variable immunodeficiency

-severe combined immunodeficiency

-Wiskott-Aldrich syndrome

Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
Children with congenital AIDS and recurrent infections
Immunomodulation
Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count
Guillain-Barré syndrome
Kawasaki disease
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Allogeneic bone marrow transplantation
Dosage form:
Solution for infusion (10%), for intravenous use only, Vial, 2.5g, 25ml
Solution for infusion (10%), for intravenous use only, Vial, 5g, 50ml
Solution for infusion (10%), for intravenous use only, Vial, 10g, 100ml